Uptake of ciprofloxacin and ofloxacin by 2 Brucella strains and their fluoroquinolone-resistant variants under different conditions. An in vitro study

Diagnostic Microbiology and Infectious Disease

Volumn 59, Issue 4, 2007, Pages 447-451

  Turkmani, Aun ^a,b   Psaroulaki, Anna ^a   Christidou, Athanasia ^a   Samoilis, George ^a   Mourad, Tayser Abu ^a   Tabaa, Darem ^b   Tselentis, Yannis ^a  

^a UNIVERSITY OF CRETE   (Greece)

^b AL BAATH UNIVERSITY   (Syrian Arab Republic)

Author keywords

Brucella; Efflux mediated mechanism of resistance; Fluoroquinolones; Uptake

Indexed keywords

AGAR; CARBONYL CYANIDE CHLOROPHENYLHYDRAZONE; CIPROFLOXACIN; LEVOFLOXACIN; MOXIFLOXACIN; NORFLOXACIN; OFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ARTICLE; BRUCELLA; BRUCELLA ABORTUS; BRUCELLA MELITENSIS; DRUG ACCUMULATION; DRUG UPTAKE; ENERGY; IN VITRO STUDY; MEMBRANE PERMEABILITY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; OUTER MEMBRANE; PH; PRIORITY JOURNAL; SPECTROPHOTOMETRY;

ANTI-INFECTIVE AGENTS; BRUCELLA ABORTUS; CARBONYL CYANIDE M-CHLOROPHENYL HYDRAZONE; CIPROFLOXACIN; CULTURE MEDIA; DRUG RESISTANCE, BACTERIAL; FLUOROQUINOLONES; HUMANS; HYDROGEN-ION CONCENTRATION; MICROBIAL SENSITIVITY TESTS; OFLOXACIN; UNCOUPLING AGENTS;

EID: 36649038351     PISSN: 07328893     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diagmicrobio.2007.06.017     Document Type: Article

References (23)

1. Akova M., Gur D., Livermore D.M., Kocagoz T., and Akalin H.E. In vitro activities of antibiotics alone and in combination against Brucella melitensis at neutral and acidic pHs. Antimicrob. Agents Chemother. 43 (1999) 1298-1300
2. Al Dahouk S., Hagen R., Nöckler K., Tomaso H., Wittig M., Scholz H., Vergnaud G., and Neubauer H. Failure of a short-term antibiotic therapy for human brucellosis using ciprofloxacin. A study on in vitro susceptibility of Brucella strains. J. Antimicrob. Chemother. 51 (2005) 352-356
3. Beadren D., and Danziger L. Mechanism of action of and resistance to quinolones. Coll. Pharm. 21 10 Pt 2 (2001) 224S-232S
4. Chierakul N., Klomsawat D., Chulavatnatol S., and Chindavijak B. Intrapulmonary pharmacokinetics of ofloxacin in drug-resistant tuberculosis. Int. J. Tuberc. Lung Dis. (2001) 278-282
5. Drlica K., and Malik M. Fluoroquinolones: action and resistance. Curr. Top. Med. Chem. (2003) 249-282
6. Easmon C., Crane J., and Blowers A. Effect of ciprofloxacin on intracellular organisms in vitro and in vivo studies. J. Antimicrob. Chemother. 18 Suppl D (1986) 43-48
7. Escribano I., Rodriguez J., Cebrian L., and Royo G. The importance of active efflux systems in the quinolone resistance of clinical isolates of Salmonella spp. Int. J. Antimicrob. Agents 24 (2004) 428-432
8. Garcia-Rodriguez J., Garcia-Sanchez J., and Trujillano I. Lack of effective bactericidal activity of new quinolones against Brucella spp. Antimicrob. Agents Chemother. 35 (1991) 756-759
9. Garcia-Rodriguez J., Garcia-Sanchez J., Trujillano I., Garcia-Sanchez E., Garcia M.I., and Fresnadillo M.J. Susceptibilities of Brucella melitensis isolates to clinafloxacin and four other new fluoroquinolones. Antimicrob. Agents Chemother. 39 (1995) 1194-1195
10. Giraud E., Blanc G., and Bouju A. Mechanisms of quinolone resistance and clonal relationship among Aeromonas salmonicida strains isolated from reared fish with furunculosis. J. Med. Microbiol. 53 (2004) 895-901
11. Hasdemir U., Chevalier J., Nordmann P., and Pages J. Detection and prevalence of active drug efflux mechanism in various multidrug-resistant Klebsiella pneumoniae strains from Turkey. J. Clin. Microbiol. 42 (2004) 2701-2706
12. Matchette L., Agrawal A., and Pfefer T. Quantum Yield Measurements of Drugs with the Potential to Interfere with Fluorescence-Based Diagnostic Devices 11th Annual FDA Science forum (2005)
13. Petra L., Bartelt E., Genschow E., Wagner J., and Hahn H. Comparison of broth microdilution, E Test, and agar dilution methods for antibiotic susceptibility testing of Campylobacter jejuni and Campylobacter coli. J. Clin. Microbiol. 41 (2003) 1062-1068
14. Piddock L.V. Mechanisms of fluoroquinolone resistance: an update 1994--1998. Drugs 58 (1999) 11-18
15. Poole K. Efflux-mediated resistance to fluoroquinolones in Gram-negative bacteria. Antimicrob. Agents Chemother. 44 (2000) 2233-2241
16. Pumbwe L., Randall L., and Woodward M. Expression of the efflux pumps genes cmeB, cmeF and the porin gene porA in multiple-antibiotic-resistant Campylobacter jejuni. J. Antimicrob. Chemother. 54 (2004) 341-347
17. Rovold K.A., and Neuhauser M. Pharmacokinetics and pharmacodynamics of fluoroquinolones. Pharmacotherapy 21 10 Pt 2 (2001) 233S-252S
18. Szybalski W., and Bryson V. Cross resistance of Escherichia coli to fifteen antibiotics. J. Bacteriol. 64 (1952) 489-499
19. Turkmani A., Ioannidis A., Christidou A., Psaroulaki A., Loukaides F., and Tselentis Y. In vitro susceptibilities of Brucella melitensis isolates to eleven antibiotics. Ann. Clin. Microbiol. Antimicrob. 5 (2006) 24
20. Van Bambeke F., Michot J., Eldere J., and Tulkens P. Quinolones in 2005: an update. Clin. Microbiol. Infect. 11 (2005) 256-280
21. Wiedemann B., and Heisig P. Mechanisms of quinolone resistance. Infection 2 (1994) S73-S79
22. Young E.J. An overview of human brucellosis. Clin. Infect. Dis. 21 (1995) 283-290
23. Zhang Q., Lin J., and Pereira S. Fluoroquinolone-resistant Campylobacter in animal reservoirs: dynamics of development, resistance mechanisms and ecological fitness. Anim. Health Res. 4 (2003) 63-71